Search Results

You are looking at 1-6 of 6

Office-based General Anesthesia for a Patient With a History of Neuroleptic Malignant Syndrome
Zakaria S. Messieha DDS
Article Category: Case Report
Volume/Issue: Volume 70: Issue 1
Online Publication Date: Mar 28, 2023
DOI: 10.2344/anpr-69-04-01
Page Range: 20 – 24

INTRODUCTION Neuroleptic malignant syndrome (NMS) is a rare, potentially life-threatening reaction to antipsychotic drugs characterized by high fever, muscle rigidity, altered mental status, and autonomic instability. It was first described in 1956 1 reportedly following a reaction to the newly introduced antipsychotic drug chlorpromazine. Interestingly, all neuroleptics have been linked to this condition including newer antipsychotics. Due to similar symptoms, it is debatable if individuals with NMS are highly susceptible to malignant

Download PDF
Kyle J. Kramer DDS, MS
Article Category: Editorial
Volume/Issue: Volume 67: Issue 3
Online Publication Date: Sep 29, 2020
Page Range: 125 – 126

In February 2019, the pharmaceutical manufacturer, American Regent, Inc (Shirley, NY) reintroduced droperidol to the US drug market. Droperidol is a butyrophenone, the same drug class as the typical antipsychotic agent haloperidol, and acts as a dopamine D2 receptor antagonist producing antiemetic and sedative-hypnotic effects. Not only has it been used along with fentanyl to produce a state of neuroleptic analgesia, previously marketed in combination as Innovar (Janssen Pharmaceutica, Beerse, Belgium) and since discontinued, but it also has

Regina A. E. Dowdy DDS,
 Shadee. T. Mansour DDS,
 James H. Cottle DDS,
 Hannah R. Mabe DDS,
 Harry B. Weprin DMD,
 Leigh E. Yarborough DMD,
 Gregory M. Ness DDS,
 Todd M. Jacobs DMD, and
 Bryant W. Cornelius DDS, MBA, MPH
Article Category: Case Report
Volume/Issue: Volume 68: Issue 1
Online Publication Date: Apr 07, 2021
Page Range: 38 – 44

despite palpable central pulses. However, after a bolus of phenylephrine (100 μg), the mean arterial pressure improved to 70 mm Hg. The patient withdrew to painful stimuli on examination. He was intubated after receiving fentanyl and an additional dose of succinylcholine (120 mg). His body temperature was measured as 97.5°F Differentials at that time included underlying cardiac abnormality (such as long QT or structural disease), toxins (serotonin syndrome or neuroleptic malignant syndrome), and hypotensive mediated arrest. Labs were drawn and were grossly normal aside

S. Maeda DDS, PhD,
 T. Miyawaki DDS, PhD,
 H. Higuchi DDS, PhD, and
 M. Shimada DDS, PhD
Article Category: Research Article
Volume/Issue: Volume 55: Issue 3
Online Publication Date: Jan 01, 2008
Page Range: 73 – 77

. 21 Richter , J. J. Current theories about the mechanisms of benzodiazepines and neuroleptic drugs. Anesthesiology 1981 . 54 : 66 – 72 . 22 Sanders , J. C. Flumazenil reverses a paradoxical reaction to intravenous midazolam in a child with uneventful prior exposure to midazolam. Paediatr Anaesth 2003 . 13 : 369 – 370

Marcos Díaz DDS and
 Daniel E. Becker DDS
Article Category: Research Article
Volume/Issue: Volume 57: Issue 1
Online Publication Date: Jan 01, 2010
Page Range: 25 – 33

uncontrolled release of calcium ions, leading to accelerated muscle metabolism and subsequent clinical features that include contracture, rigidity, severe hyperthermia, metabolic acidosis, and tachycardia. In addition to the genetic susceptibility mentioned previously, certain myopathies, including Duchenne Muscular Dystrophy, central core disease, neuroleptic malignant syndrome, and King-Denborough syndrome, present a risk for MH. 15 The most widely used test for determining MH susceptibility is the halothane-caffeine contracture test (CHCT). This test is performed

Daniel E. Becker DDS
Article Category: Research Article
Volume/Issue: Volume 55: Issue 3
Online Publication Date: Jan 01, 2008
Page Range: 89 – 99

antidepressants may not experience adequate pain relief from codeine or its derivatives. 7 , 8 Antipsychotic Drugs The psychoses include schizophrenia and other delusional impairments in which patients have difficulty in comprehending reality. These disorders are managed using antipsychotic drugs. Although less descriptive, these agents may also be referred to as “neuroleptics,” a term less offensive to the patient. Despite our poor understanding of their precise mechanisms and their myriad side effects, it cannot be disputed that